UK HealthCare logo

Practice areas

  • Gastrointestinal and Colorectal Cancer Team
  • Liver Cancer Team
  • Medical Oncology
  • Pancreas Cancer Team

Faculty rank

Professor of Medicine

Clinic information

Clinical interests

  • Colorectal Cancer
  • Gastrointestinal Cancer
  • Hematology
  • Medical Oncology



University of Vermont, College of Medicine, Burlington


University of Kentucky, Lexington


Medical Oncology and Hematology, University of Kentucky, Lexington

Certifications or Special training

American Board of Internal Medicine
American Board of Internal Medicine, Hematology

Additional information


My name is Philip DeSimone; I received my medical degree from the University of Vermont, College of Medicine, Burlington. I completed a fellowship in Medical Oncology and Hematology at the University of Kentucky, Lexington.

I am board certified by the American Board of Internal Medicine in Hematology.


  1. Arnold SM, Rinehart JJ, Tsakalozou E, Eckardt JR, Fields SZ, Shelton BJ, DeSimone PA, Kee BK, Moscow JA, Leggas M.
    A phase I study of 7-t-butyldimethylsilyl-10-hydroxycamptothecin in adult patients with refractory or metastatic solid malignancies.
    Clin Cancer Res. 2010 Jan 15;16(2):673-80.
  2. Bence AK, Anderson EB, Halepota MA, Doukas MA, DeSimone PA, Davis GA, Smith DA, Koch KM, Stead AG, Mangum S, Bowen CJ, Spector NL, Hsieh S, Adams VR.
    Phase I pharmacokinetic studies evaluating single and multiple doses of oral GW572016, a dual EGFR-ErbB2 inhibitor, in healthy subjects.
    Invest New Drugs. 2005 Jan;23(1):39-49.
  3. Thompson JS, Haist SA, DeSimone PA, Engelberg J, Rich EC.
    The accelerated internal medicine program at the University of Kentucky.
    Ann Intern Med. 1992 Jun 15;116(12 Pt 2):1084-7.